Krystal Biotech, Inc. 8-K Filing: Key Corporate Updates on December 18, 2024

Based on the provided XML section of a financial report, here are the key insights and information extracted:

1. Filing Type: The document is an 8-K filing, which is typically used to report unscheduled material events or corporate changes that are of importance to shareholders.
2. Company Information:

• Name: Krystal Biotech, Inc.
• State of Incorporation: Delaware (DE)
• CIK Number: 0001711279
• SEC File Number: 001-38210
• EIN: 82-1080209
• Address: 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203
• Phone Number: 412-586-5830

3. Filing Date: The report is dated December 18, 2024.
4. Context ID: The context ID provided is "c-1," which may refer to the specific reporting context for this filing, although further details are not available in the extracted text.
5. Start and End Date: The reporting period starts and ends on December 18, 2024, indicating that this may be a specific event that occurred on this date.

This information is foundational for understanding the nature of the filing and the company involved. Further analysis would require additional context or details from the content of the 8-K filing itself.